|1.||Yan, Ping: 1 article (03/2012)|
|2.||Zhang, Chun-Li: 1 article (03/2012)|
|3.||Yu, Ming-Ming: 1 article (03/2012)|
|4.||Wang, Rong-Fu: 1 article (03/2012)|
|5.||Lu, Xia: 1 article (03/2012)|
|6.||Liu, Meng: 1 article (03/2012)|
02/01/1971 - "[Clinical studies on serum leucyl glycyl glycine hydrolyzing enzyme in cancer. "
01/01/1971 - "[Clinical studies on serum leucyl glycyl glycine hydrolyzing enzyme in cancer. "
09/20/1961 - "[Research on the modification of amino-peptidase in the blood of healthy subjects and tumor patients by D-leucine and D-leucyl-glycyl-glycine]."
03/01/2012 - "To explore a tumor peptide imaging agent Arginine-Arginine-Leucine (Tyr-Cys-Gly-Gly-Arg-Arg- Leu-Gly-Gly-Cys, tripeptide RRL [tRRL]) that targeted to tumor cells and tumor-derived endothelial cells (TDECs) and primarily investigate the possible relationship between tRRL and vascular endothelial growth factor receptor 2 (VEGFR-2). "
|2.||Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)
|3.||Glycine (Aminoacetic Acid)